SYNCOPE
Clinical trials for SYNCOPE explained in plain language.
Never miss a new study
Get alerted when new SYNCOPE trials appear
Sign up with your email to follow new studies for SYNCOPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study: could a wearable heart monitor after fainting save lives?
Disease control Recruiting nowThis study tests whether using a portable heart monitor for 15 days after a fainting episode can detect dangerous heart rhythms that standard short-term monitoring might miss. About 580 adults who fainted and are at medium or high risk will be randomly assigned to either usual ca…
Matched conditions: SYNCOPE
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
AI-Powered patch could replace ultrasound for heart checkups
Diagnosis Recruiting nowThis study tests an artificial intelligence program that analyzes heart rhythm data from a small, wearable patch to estimate how well the heart pumps blood. Researchers will compare the AI's results to standard ultrasound in 2,000 adults. If accurate, this could offer a simpler, …
Matched conditions: SYNCOPE
Sponsor: Peerbridge Health, Inc • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Bubbly water may keep you from fainting
Symptom relief Recruiting nowThis study looks at whether carbonated water can help people stay steady on their feet and avoid fainting. Drinking water is known to raise blood pressure, but researchers want to see if the bubbles in carbonated water add an extra benefit by stretching the stomach. 25 healthy ad…
Matched conditions: SYNCOPE
Phase: NA • Sponsor: Simon Fraser University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Should Low-Risk fainting patients stay overnight? new trial aims to find out
Knowledge-focused Recruiting nowThis study looks at whether keeping low- and intermediate-risk fainting patients in the hospital for 24 hours with a heart monitor is better than sending them home right away. About 640 adults will be randomly assigned to either stay or go home. The goal is to see if the longer m…
Matched conditions: SYNCOPE
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Millions of drug alerts may be misleading: massive study to find out which QT drugs actually harm hearts
Knowledge-focused Recruiting nowThis study looks at whether certain medications known to affect the heart's electrical activity (QT-prolonging drugs) actually cause major heart problems in hospitalized adults. Researchers will analyze data from over 990,000 patients across Ontario hospitals, comparing those who…
Matched conditions: SYNCOPE
Sponsor: St. Joseph's Healthcare Hamilton • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Heart monitor study tracks Real-World performance
Knowledge-focused Recruiting nowThis study watches how well a small heart monitor (BIOMONITOR III) works in routine medical care for 1400 people. It tracks how quickly the device finds hidden heart rhythm problems like atrial fibrillation or fainting spells. The goal is to learn about the device's real-life per…
Matched conditions: SYNCOPE
Sponsor: Biotronik SE & Co. KG • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Hidden heart genes may trigger sudden death in epilepsy patients
Knowledge-focused Recruiting nowThis study from Mayo Clinic looks for genetic heart conditions in people with epilepsy that might raise the risk of sudden unexpected death (SUDEP). Researchers will analyze DNA from 600 adults aged 18-50 with epilepsy or related symptoms, plus their blood relatives. The goal is …
Matched conditions: SYNCOPE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:07 UTC